期刊文献+

Akt和mTOR蛋白在肾透明细胞癌中的表达及意义 被引量:1

The expression and significance of AKT and mTOR in renal cell carcinoma
下载PDF
导出
摘要 目的探讨Akt和mTOR蛋白是否可作为一种新的诊断肾透明细胞癌标志和药物靶向治疗的靶点。方法采用免疫组化和逆转录聚合酶链反应(RT-PCR)技术对60例肾透明细胞癌组织和30例癌旁正常肾组织中的Akt和mTOR的蛋白及mRNA表达进行检测分析。结果 Akt和mTOR蛋白及mRNA在肾透明细胞癌组织中均呈高表达,在癌旁正常组织中均呈低表达(P<0.05);mTOR和Akt蛋白在肾细胞癌组织中的阳性表达率呈正相关。结论 Akt、mTOR蛋白在肾透明细胞癌中的高表达与肾细胞癌的发生有关,可作为一种新的肾细胞癌诊断标志物。 Objective To explore an applicable marker for diagnosis and a target to develop therapeutic agents for renal clear cell carcinoma. Methods mTOR, Akt protein and mRNA expression in carcinoma tissues in 60 patients and adjacent tissues in 30 patientswith clear cell renal cell carcinoma were detected by immunohistochemistry (IHC) and reverse transcriptase polymerase chain reaction ( RT - PCR ). Results The results showed the positive expression rate of Akt in carcinoma tissue was significantly higher than adjacent tissues; the positive expression rate of mTOR in carcinoma tissue was significantly higher than that in adjacent tissues (P 〈 0.05 ). RT - PCR results : mRNA expression of Akt and mTOR in carcinoma tissue was higher than that in adjacent tissues ; Most adjacent tissues were Positive for mRNA expression of Akt and roTOR in adjacent tissues. Conclusion mTOR and Akt protein expression may he an applicable marker for diagnosis and/or a target to develop therapeutic agents for clear cell renal cell carcinoma.
出处 《宁夏医学杂志》 CAS 2012年第12期1194-1196,I0001,共4页 Ningxia Medical Journal
关键词 肾透明细胞癌 MTOR AKT蛋白 转道通路 Renal clear cell carcinoma roTOR protein Akt protein Signal transduction pathway
  • 相关文献

参考文献6

  • 1冯美江,丁新生.Akt与细胞生存[J].国外医学(分子生物学分册),2002,24(5):283-285. 被引量:23
  • 2Zhou X,Tan M,Stone Hawthorne V. Activation of the Akt/mammalian target of apamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers[J].Clinical Cancer Research,2004,(20):6779-6788.
  • 3郭应禄;周利群.坎贝尔-沃尔什泌尿外科学[M]北京:北京大学医学出版社,20091668-1669.
  • 4郭琳,王强.PI3K/Akt/mTOR信号传导通路与恶性肿瘤浸润和转移的研究进展[J].现代肿瘤医学,2009,17(8):1585-1589. 被引量:24
  • 5Albert JM,Kim KW,Cao C. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer[J].Molecular Cancer Therapeutics,2006.1183-1189.
  • 6Cho D,Signoretti S,Regan M. The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer[J].Clinical Cancer Research,2007,(22):758-763.

二级参考文献49

  • 1Klippel A,Escobedo MA,Wachowicz MS,et al.Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation[J].Mol Cell Biol,1998,18(10):5699-5711.
  • 2Collado M,Medema RH,Garcia-Cao I,et al.Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1[J].J Biol Chem,2000,275(29):21960-21968.
  • 3Graff JR,Konicek BW,McNulty AM,et al.Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression[J].J Biol Chem,2000,275(32):24500-24505.
  • 4Shtivelman E,Sussman J,Stokoe D.A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle[J].Curr Biol,2002,12(11):919-924.
  • 5Mayo LD,Donner DB.A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of mdm2 from the cyto-plasm to the nucleus[J].Proc Natl Acad Sci USA,2001,98(20):11598-11603.
  • 6Henshall DC,Araki T,Schindler CK,et al.Activation of bcl-2 associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death[J].J Neurosci,2002,22(19):8458-8465.
  • 7Xin M,Deng X.Nicotine inactivation of the proapoptotic function of Bax through phosphorylation[J].J Biol Chem,2005,280(11):10781-10789.
  • 8Bartling B,Tostlebe H,Darmer D,et al.Shear stress-dependent expression of apoptosis-regulating genes in endothelial cells[J].Biochem Biophys Res Commun,2000,278(3):740-746.
  • 9Li N,Banin S,Ouyang H,et al.ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks[J].J Biol Chem,2001,276(12):8898-8903.
  • 10Gibson EM,Henson ES,Haney N,et al.Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release[J].Cancer Res,2002,62(2):488-496.

共引文献45

同被引文献15

  • 1谢海萍,杨策尧,申丽娟.Akt2及其在恶性肿瘤侵袭和转移中的研究进展[J].昆明医科大学学报,2012,33(S1):23-26. 被引量:1
  • 2苗丽君,王静.Akt与肿瘤的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(5):406-409. 被引量:38
  • 3Kang Y,Massague J. Epithelial mesenehymal transitions:twist in development and metastasis[J].Cell,2004,118(3) :277-279.
  • 4Cheng GZ,Zhang W,Wang LH,et al.Regulation of cancer cell survival, migration, and invasion by Twist:Akt2 comes to interplay[J].Cancer Res,2008,68(4):957-960.
  • 5Zhang X,Wang Q,Ling MT,et al.Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells[J].Int J Cancer,2007,120(9):1891-1898.
  • 6Chappell WH,Steelman LS,Long GM,et a1.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: Rationale and impotance to inhibiting these pathways in human health[J].Oncotarget,2011,2(3):135-164.
  • 7Liu Z, Zhu J,Gao H,et a1.miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer[J]. Int J Oncol,2012,40(5):1553-1560.
  • 8Cheng GZ,Chan J,Wang Q,et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration,invasion, and resistance to paclitaxel[J].CancerRes, 2007,67(5):1979-1987.
  • 9刘瑞鸣,徐静.Twist与恶性肿瘤关系的研究[J].广西医科大学学报,2009,26(2):326-328. 被引量:7
  • 10刘晓燕,王丽,张志霞,李娟,何涛.Twist基因RT-PCR检测方法的建立[J].西南军医,2010,12(4):625-627. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部